Through pro-inflammatory cytokine release (TNF-α, IFN-γ), CAR-NKT cells have the potential to reshape the immune activity inside the tumor microenvironment by promoting dendritic cell proliferation via CD40-CD40L interaction and antigen presentation with subsequent activation of CD4+ and CD8+ tumor-infiltrating lymphocytes. This evidence concerns the gene CD40 and neoplasm.